Juvenile Bullous Pemphigoid with Similarity Clinical Features to Chronic Bullous Disease of Childhood

Main Article Content

Wuri Puspita Rani
Fitriana Yusiyanti Dewi
Saladina Na`imah Tamimi Handoko
Anggelita Berkah Pratami Turut Yudha

Abstract

Introduction: Autoimmune bullous disease (ABD) is a specific autoimmune skin disease characterized by subepidermal vesicles and bullae. In pediatrics, there is an autoimmune bullous disease controversy with clinical clusters of jewel on Chronic bullous disease of childhood (CBDC) but dominant IgG autoantibodies. A similar clinical presentation challenges diagnosis; thus, supporting studies on direct immunofluorescence (DIF) as a specific autoantibody factor are necessary.


Case: A 10-year-old boy with clinically tense-walled blisters with or without an erythematous base is itchy all over his body, with a predominance of palmoplantar, neck, inguinal, and axillary, presented by erosions, crusts, and a partial cluster of jewels lesion with mucosal involvement. A complete blood count shows leukocytosis and eosinophilia. Hematoxylin-eosin (HE) staining revealed a subepidermal cleft with eosinophil predominance, while direct immunofluorescence (DIF) revealed IgG deposits in the basal membrana and intercellular parts of the basal stratum.


Discussion: Histopathology reveals subepidermal blisters of eosinophil dominance, and direct immunofluorescence (DIF) examination reveals IgG autoantibody deposit dominance, verifying the diagnosis of juvenile bullous pemphigoid. Given that BP180 (BPAG2) is one of the autoantigens involved, there may be similarities between the histology and clinical presentation of Bullous pemphigoid (BP) and CBDC.


Conclusion: Autoimmune bullous diseases are difficult to differentiate clinically, histological studies and direct immunofluorescence are necessary to make a diagnosis.

Article Details

How to Cite
Wuri Puspita Rani, Fitriana Yusiyanti Dewi, Saladina Na`imah Tamimi Handoko, & Anggelita Berkah Pratami Turut Yudha. (2023). Juvenile Bullous Pemphigoid with Similarity Clinical Features to Chronic Bullous Disease of Childhood. International Journal of Medical Science and Clinical Research Studies, 3(11), 2641–2645. https://doi.org/10.47191/ijmscrs/v3-i11-19
Section
Articles

References

I. Heckler I, Hong M, Sinha A, Venkataraman I. Serological Biomarkers and Their Detection in Autoimmune Bullous Skin Diseases. Dermatol Pract Concept. 2022;12(2):e2022116.

II. Daniel BS, Murrel DF. Review of autoimmune blistering disease: the Pemphigoid disease. JEADV. 2019;33:1685-1694.

III. Kong YL, Lim YL, Chandran NS. Retrospective study on autoimmune blistering disease in paediatric patients. Paediatr Dermatol.2015; 326: 845-825.

IV. Gupta V. Clinicoepidemiological study of vesiculobullous disorders in pediatric age group. Indian J Paediatr Dermatol. 2015;16:9-16.

V. Faris Oumeish, Hamdi Hamad, Hussain Tukmatchy, Niall Scully and Mohammed Al Abadie, Bullous Pemphigoid in Children: Clinical Presentation, Pathology and Management. Clin Res Dermatol Open Access. 2021;8(1): 1-4.

VI. Biradar S.M, Dhanavidya S, Kavya P, Keerthi T, Sunanda N et al. Bullous Pemphigoid A Rare Autoimune Disease: A case Report. International Journal of Medicine and Medical Research. 2018;4:2:20-23.

VII. Denise Miyamoto, Claudia Giuli Santi, Valéria Aoki, Celina Wakisaka Maruta. Bullous pemphigoid. An Bras Dermatol. 2019;94(2):133-46.

VIII. Nemeth AJ, Klein AD, Gould EW, Schachner LA. Childhood bullous pemphigoid. Clinical and immunologic features, treatment, and prognosis. Arch Dermatol. 1991;127:378-86.

IX. Waisbord-Zinman O, ben-Amitai D, Cohen AD, et al. Bullous pemphigoid in infancy:Clinical and epidemiologic characteristic. J Am Acad Dermatol.2008;58:41-8.

X. Patsatsi A. Chronic Bullous Disease or Linear IgA Dermatosis of Childhood - Revisited. J Genet Syndr Gene Ther. 2013;4:151.

XI. Diaz M S, Morita L, Ferrari B, et al. Linear IgA Bullous Dermatosis: A Series of 17 Cases. Actas Dermo-Sifiliograficas.2019;110(8):673-80.

XII. Donna A. Culton DA, Liu Z, Diaz LA. Bullous pemphigoid. Dalam Sewon Kang, Masayuki A, Anna LB, Alexander HE, David JM, Amy JM.Fitzpatrick’s Dermatology in General Medicine 9th ed. New York:Mc Graw Hill co.2019;54:944-59.

XIII. Sansaric F, Stein SL, Peronic-Rosic V. Autoimmune bullous disease in childhood. Clin Dermatol.2012;30:114-27.

XIV. Saenz AM, Gonzales F, Ciroco A, Tacaronte IM, Fajardo JE, Calebotta A. Childhood bullous pemphigoid: A case report and 10-year follow-up. Int J Dermatol.2007;46;508-10.

XV. Ghohestani R, Novotney J, Chaudary M, Agah RS. Bullous Pemphigoid: From the Beside to the Research Laboratory. Clin Dermatol.2001;19:690-6.

XVI. Gareth Edwards, Gilles FH Diercks, Marc AJ Seelen, Barbara Horvath, Martijn BA van Doorn, Jeffrey Damman. Complement Activation in Autoimmune Bullous Dermatoses: A Comprehensive Review. Frontiers in Immunology. 2019;10:1477.

XVII. Nicholas MW, Rao CL, Hall III RP. Linear Immunoglobulin A dermatosis and chronic bullous disease of childhood. In:Sewon Kang, Masayuki A, Anna LB, Alexander HE, David JM, Amy JM.Fitzpatrick’s Dermatology in General Medicine 9th ed. New York:Mc Graw Hill co.2019;58:992-1001.

XVIII. Woodley DT, Chen M. Epidermolysis bullosa acquisita. In:Sewon Kang, Masayuki A, Anna LB, Alexander HE, David JM, Amy JM. Fitzpatrick’s Dermatology in General Medicine 9th ed. New York:Mc Graw Hill co.2019;56:971-80.